Drug Shortage Report for RASILEZ
| Report ID | 196602 |
| Drug Identification Number | 02302071 |
| Brand name | RASILEZ |
| Common or Proper name | Rasilez |
| Company Name | NODEN PHARMA DAC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALISKIREN |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28 |
| ATC code | C09XA |
| ATC description | OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2023-08-01 |
| Actual start date | 2023-08-31 |
| Estimated end date | 2024-07-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-10-03 |
| Company comments | Rasilez 150mg x 28s is still available in the market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | D'OLIER CHAMBERS, 16A D'OLIER STREET DUBLIN, DUBLIN IRELAND |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-10-03 | French | Compare |
| v4 | 2023-10-03 | English | Compare |
| v3 | 2023-08-02 | English | Compare |
| v2 | 2023-06-27 | French | Compare |
| v1 | 2023-06-27 | English | Compare |
Showing 1 to 5 of 5